Very excited to have two guest lecturers from @RTI_Intl in my class today, Molly Chen & Elizabeth Fitch, who will discuss: "Measuring large-scale change: how to evaluate policy" 🔎
Interested in the readings for the class?📖📖📖
This thread has them 1/n
UN Resolution Highlighting Evaluation Capacity Building for the Achievement of Development Results at Country Level
WHO Framework and Standards for Country Health Information Systems, 2nd edition
First up: a discussion of the "let the virus" rip strategy pushed by the Great Barrington Declaration.
GBD wanted herd immunity from natural infection.
They influenced policy:
"From Oct 2020-Jan 2021, we allowed 270,000 people to die in the US," said Prof Lauren Ancel Meyers
Fascinating discussion of "overshoot," as described by @CT_Bergstrom & @nataliexdean. Prof Meyers says that Britain's strategy of regular testing is valuable in this context.
I've been listening to a LOT of Abby Lincoln & Max Roach, one of the finest musical duos in history
It got me wondering: which other musicians who are/were in a romantic relationship produced great music? Let me know who I missed
1/11
Honestly, up there with Lincoln & Roach it HAS to be Doug & Jean Carn. Their 1973 album Revelation is one of my favorites of theirs. The title track is 🔥🔥🔥
2/11
Folks, I'm not going chronologically, I'm all over the map.
Next up is one of the world's best electronic duos, Matmos: Martin Schmidt & Drew Daniel.
I had to start of course with Marshall Allen, who is 96. I saw him perform a few years ago with the Sun Ra Arkestra in London, @gillespeterson's Worldwide Awards. He was ON FIRE. In 2020 they put out a great new album (their first in over 20 years) 2/11
Yes, we still have a LONG way to go. Our team co-authored a new study of the pipeline of candidate products for neglected diseases. There are still VERY few candidates for diarrheal diseases, salmonella infections, helminths & kinetoplastid infections 2/n
BUT, there has been notable progress over the last 20 years:
💲 Since 2007, the research group @PCuresResearch has tracked annual financing of R&D for these diseases. In FY2007, there was $2.7B in funding. In FY2018, funding reached $4B, a new high. 3/n